FULLER & THALER ASSET MANAGEMENT, INC.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1082327
SAN MATEO, CA
Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$30,193,772
+$18,686,283 QoQ
Shares Held
179,149
+105.1% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#86
of 768 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $857,277,969 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,615,816 | $189,386,930 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
6,240,240 | $153,572,306 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,697 | $119,580,255 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
2,331,821 | $110,225,178 | |
| 5 | LQDA |
Liquidia Corp
|
1,209,604 | $96,441,726 | |
| 6 | PRGO |
PERRIGO Co plc
|
7,498,227 | $77,906,578 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,781 | $59,106,672 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
179,149 | $30,193,772 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,193,772 | 179,149 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $11,507,489 | 87,350 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||